Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

(2020) Yushun Wan et al.   JOURNAL OF VIROLOGY

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

(2020) Peter Richardson et al.   LANCET

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diabetes is a risk factor for the progression and prognosis of COVID-19

(2020) Weina Guo et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

COVID-19 and Italy: what next?

(2020) Andrea Remuzzi et al.   LANCET

COVID-19: consider cytokine storm syndromes and immunosuppression

(2020) Puja Mehta et al.   LANCET

Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial

(2018) Jose V. Perez-Moreiras et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection

(2010) R. Allard et al.   DIABETES CARE

The sweeter side of ACE2: Physiological evidence for a role in diabetes

(2008) Sharell M. Bindom et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY